25 Tex. Admin. Code § 229.2 - Definitions
The following words and terms when used in this subchapter shall have the following meaning unless the context clearly indicates otherwise.
(1) Department--Department of State Health Services.
(2) Calendar year--January 1 through December 31 of each year.
(3) Exclusivity--A Federal Drug Administration (FDA) granted delay on approval of competitor drugs that attaches upon FDA's approval of a drug.
(4) Patent--A property right issued by the United States Patent and Trademark Office to exclude others from making, using, offering for sale, or selling an invention for a limited time.
(5) Patent exclusivity--Rights resulting from a drug manufacturer holding an unexpired patent, or exclusivity, or both.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.